Citigroup’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.9K | Sell |
34,759
-7,543
| -18% | -$18.6K | ﹤0.01% | 3758 |
|
|
2025
Q1 | $84.2K | Sell |
42,302
-5,129
| -11% | -$10.2K | ﹤0.01% | 3922 |
|
|
2024
Q4 | $138K | Sell |
47,431
-640
| -1% | -$1.87K | ﹤0.01% | 3821 |
|
|
2024
Q3 | $186K | Buy |
48,071
+30,560
| +175% | +$118K | ﹤0.01% | 3625 |
|
|
2024
Q2 | $90K | Sell |
17,511
-26,459
| -60% | -$136K | ﹤0.01% | 3540 |
|
|
2024
Q1 | $308K | Buy |
43,970
+33,035
| +302% | +$231K | ﹤0.01% | 3098 |
|
|
2023
Q4 | $96.9K | Sell |
10,935
-45,258
| -81% | -$401K | ﹤0.01% | 3473 |
|
|
2023
Q3 | $536K | Buy |
56,193
+42,032
| +297% | +$401K | ﹤0.01% | 2359 |
|
|
2023
Q2 | $207K | Buy |
14,161
+5,302
| +60% | +$77.7K | ﹤0.01% | 3221 |
|
|
2023
Q1 | $109K | Buy |
8,859
+5,272
| +147% | +$64.8K | ﹤0.01% | 3354 |
|
|
2022
Q4 | $66.6K | Buy |
+3,587
| New | +$66.6K | ﹤0.01% | 3498 |
|